BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Ocular Therapeutix Inc. (NASDAQ:OCUL)

8 posts

Biotech NewsOcular Therapeutix (OCUL) Has $598.6M as Its Eye Drug Approaches a Filing Milestone

  • BioTech Health X
  • November 1, 2026
Wall Street likes biotechnology stocks for a familiar reason: promising science can eventually become profitable medicine. A breakthrough…
0 Shares
0
0
0
0
0
0
0

Biotech News5 Best Biotech Stocks Under $10 to Buy Now

  • BioTech Health X
  • November 1, 2026
5. Savara Inc. (NASDAQ:SVRA) Number of Hedge Fund Holders: 36Market Capitalization: $1.03 billionShare Price: $4.86 Savara Inc. (NASDAQ:…
0 Shares
0
0
0
0
0
0
0

Biotech NewsCould Ocular Therapeutix (OCUL) Be a Smart Long-Term Bet in Ophthalmology?

  • BioTech Health X
  • June 14, 2026
We recently published our article Top 5 Small-Cap Biotech Stocks That Could Surge 100%. To read the full…
0 Shares
0
0
0
0
0
0
0

Biotech NewsTop 5 Small-Cap Biotech Stocks That Could Surge 100%

  • BioTech Health X
  • June 12, 2026
In this article, we break down the Top 5 Small-Cap Biotech Stocks That Could Surge 100%. For investors…
0 Shares
0
0
0
0
0
0
0

Biotech NewsIs Ocular Therapeutix (OCUL) a Smart Eye-Care Stock to Buy Before Its Next Big Catalyst?

  • BioTech Health X
  • May 23, 2026
We recently published our article Top 5 Small-Cap Biotech Stocks With Billion-Dollar Upside Potential. To read the full…
0 Shares
0
0
0
0
0
0
0

Biotech NewsTop 5 Small-Cap Biotech Stocks With Billion-Dollar Upside Potential

  • BioTech Health X
  • May 23, 2026
In this article, we break down the Top 5 Small-Cap Biotech Stocks With Billion-Dollar Upside Potential. For investors…
0 Shares
0
0
0
0
0
0
0

Biotech NewsAnalysts Boost Target to $24 as Ocular Therapeutix (OCUL) Nears Major Catalyst

  • BioTech Health X
  • December 6, 2025
Ocular Therapeutix, Inc. is a biotechnology company dedicated to transforming the treatment landscape for serious ocular diseases through…
0 Shares
0
0
0
0
0
0
0

Biotech NewsOcular Therapeutix (OCUL) Raises $475M to Fund Phase 3 Axpaxli Trials

  • BioTech Health X
  • October 3, 2025
Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a biopharmaceutical company dedicated to developing and commercializing innovative therapies for eye…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • 10 Healthcare and Insurance Stocks to Buy as Democrats Take Control
  • 5 Healthcare and Insurance Stocks to Buy as Democrats Take Control
  • Johnson & Johnson (JNJ) Flexes Its Oncology Muscle With 16.4% Sales Growth
  • Would You Still Dare to Invest in Revolution Medicines (RVMD)?
  • Merck (MRK) Has an $8.6 Billion Cancer Franchise and a Succession Plan to Prove
Featured Posts
    • November 11, 2026
    10 Healthcare and Insurance Stocks to Buy as Democrats Take Control
    • November 11, 2026
    5 Healthcare and Insurance Stocks to Buy as Democrats Take Control
    • November 6, 2026
    Johnson & Johnson (JNJ) Flexes Its Oncology Muscle With 16.4% Sales Growth
    • November 6, 2026
    Would You Still Dare to Invest in Revolution Medicines (RVMD)?
    • November 6, 2026
    Merck (MRK) Has an $8.6 Billion Cancer Franchise and a Succession Plan to Prove
Recent Posts
  • AbbVie (ABBV) Delivers $17.4 Billion in Revenue
    • November 6, 2026
  • Pfizer (PFE) Gets an Oncology Boost as Padcev Sales Surge 55%
    • November 6, 2026
  • Guardant Health (GH) Posts 44% Revenue Growth as Liquid Biopsy Gains Ground
    • November 6, 2026
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (6)
  • Biotech News (1,187)
  • Uncategorized (2)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top